✦ LIBER ✦

MxA protein assay for optimal monitoring of IFN-β bioactivity in the treatment of MS patients

✍ Scribed by A.-M. Vallittu; J.-P. Erälinna; J. Ilonen; A. A. Salmi; M. Waris

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The importance of measuring IFNβ bioacti

✍ Andrew R. Pachner; Donna Dail; Elena Pak; Kavitha Narayan 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 223 KB

BAb and MxA as Functional Biomarkers in

✍ Cakal, Bulent; Uygunoglu, Ugur; Saip, Sabahattin; Altintas, Ayse; Siva, Aksel; B 📂 Article 📅 2014 🏛 Taylor and Francis Group 🌐 English ⚖ 320 KB

Single-tube quantitative RT-PCR for moni

✍ Moravcová, J; Muchová, S; Kalbáčová, R; Haškovec, C 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 85 KB

Long-term effect of IFNβ1b treatment on

✍ Abel Gayo; Lourdes Mozo; Ana Suárez; Alberto Tuñon; Carlos Lahoz; Carmen Gutiérr 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 832 KB

Performance of two commercial blood IFN-

✍ M. Bocchino; A. Matarese; B. Bellofiore; P. Giacomelli; G. Santoro; N. Balato; F 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 158 KB

Clinical utility of the ARCHITECT HCV Ag

✍ Johannes Vermehren; Simone Susser; Annemarie Berger; Dany Perner; Kai-Henrik Pei 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 300 KB